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Abstract 21 
Objective: To assess the influence of a home-based exercise intervention on indices of 22 
health-related quality of life (HRQOL) in persons with spinal cord injury (SCI). 23 
Design: This was a randomized controlled trial (HOMEX-SCI; ISRCTN57096451). After 24 
baseline laboratory testing and a week of free-living physical activity monitoring, eligible 25 
participants were randomly assigned (2:1 allocation ratio) to a home-based moderate-26 
intensity upper-body exercise intervention (INT, n = 13), or a lifestyle maintenance control 27 
group (CON, n = 8), for 6 weeks. 28 
Setting: Home-based with short laboratory visits immediately before and after the 29 
intervention/control period. 30 
Participants: Twenty-one inactive participants with chronic (> 1 year) SCI (injury level 31 
range, T4 – L5). 32 
Intervention:                                                                              33 
               -             -                           2 peak]) arm-crank exercise per 34 
week for 6 weeks. Participants assigned to the control group (CON) were asked to maintain 35 
their habitual physical activity behaviour. 36 
Main Outcome Measures: Secondary outcome measures were assessed, including physical 37 
and emotional component scores (PCS and MCS) of health-related quality of life (SF-36), 38 
fatigue, global fatigue (FSS) and shoulder pain index (WUSPI). Cardiorespiratory fitness 39 
(CRF), objectively measured habitual moderate-to-vigorous physical activity (MVPA) and 40 
exercise self-efficacy (ESE) were also assessed at baseline and follow-up. 41 
Results. Changes in the PCS (P = 0.017) of the SF-36, ESE (P = 0.011) and FSS (P = 0.036) 42 
were significantly different between the two groups, with moderate to large effect sizes (d = 43 
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0.75 – 1.37 .         HRQ L                       ‘      ’    ‘           ’          44 
inferences in favour of the INT group following the 6-week exercise intervention. Changes in 45 
ESE were significantly (P < 0.01) associated with changes in PCS (r = 0.62) and MCS (r = 46 
0.71), FSS (r = -0.71) and global fatigue (r = 0.57). 47 
Conclusions. A 6-week upper-body exercise intervention improved indices of HRQOL in 48 
persons with SCI. Improvements were associated with increases in ESE. While this 49 
intervention demonstrated a positive impact on perceived physical functioning, future 50 
interventions should aim to support social and mental functioning and exercise maintenance. 51 
 52 
Key words: Spinal cord injury; exercise intervention; health and wellbeing; self efficacy; 53 
quality of life 54 
 55 
 56 
 57 
 58 
 59 
 60 
 61 
 62 
 63 
 64 
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Abbreviations: 65 
CON- Lifestyle maintenance control group, 66 
ESE- Exercise Self-Efficacy 67 
ESES- Exercise Self-Efficacy Scale 68 
FSS- fatigue severity scale 69 
HOMEX-SCI- Home-based upper-body exercise randomized controlled trial, 70 
HRQOL- Health-related quality of life 71 
INT- Home-based moderate-intensity upper-body exercise intervention group, 72 
MVPA- moderate-to-vigorous physical activity, 73 
SCI- spinal cord injury, 74 
SF36- short form 36 health survey, 75 
CRF- cardiorespiratory fitness, 76 
   2peak - peak oxygen uptake, 77 
WUSPI- wheelchair user shoulder pain index 78 
 79 
 80 
 81 
 82 
 83 
 84 
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INTRODUCTION 85 
Disability can negatively impact physical activity behaviour 
1
. The reasons for the adoption 86 
of a more sedentary lifestyle are multifactorial, but the perceived psychosocial and 87 
environmental barriers to engage in physical activity are numerous for wheelchair users 88 
living with a spinal cord injury (SCI) 
2, 3
. Consequently, persons with SCI are relatively 89 
inactive 
4 
and new ways to support the initiation of physical activity in this population are 90 
needed. 91 
Besides an increased incidence of chronic diseases (e.g. cardiovascular disease, type 2 92 
diabetes) 
5
, persons with SCI have significantly elevated levels of fatigue, anxiety, depression 93 
and poorer exercise self-efficacy (ESE) compared to non-disabled controls 
6, 7
. This is 94 
important because physical activity can improve quality of life for people with SCI and ESE 95 
is considered a modifiable predictor of physical activity behaviour change, specifically in this 96 
population 
8-12
. Therefore, it is essential to develop strategies capable of improving exercise 97 
self-efficacy in order to increase physical activity participation and accrue enhancements in 98 
quality of life.  99 
Educational interventions, covering physical activity, nutrition and lifestyle management, 100 
have been shown to improve exercise self-efficacy and self-rated health, and result in fewer 101 
and less severe secondary conditions in persons with SCI 
13, 14
. Following a 9-month, twice-102 
weekly strength and arm-ergometry intervention, participants reported significantly higher 103 
levels of satisfaction with physical function, level of perceived health, overall quality of life 104 
and less pain than a control group 
15
. However, these findings have not been demonstrated 105 
with shorter term, higher volume aerobic exercise training per se. Moreover, it has previously 106 
been suggested that upper-body exercise, primarily arm-crank ergometry as a training 107 
modality, might contribute to shoulder overuse injuries and trigger the onset of pain 
16
. 108 
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Therefore, the available evidence is currently inconclusive about whether upper-body arm-109 
crank exercise is an effective treatment modality for improving health-related quality of life 110 
(HRQOL) in persons with SCI. Furthermore, a lack of access to gym facilities and exercise 111 
equipment, as well as poor information and support, have been identified as key barriers to 112 
exercise for adults with SCI 17-19. Therefore, the provision of exercise equipment and a 113 
tailored exercise programme within a home setting could provide a mastery experience and 114 
help enhance ESE in people with SCI.  115 
A recent meta-analysis on physical activity and wellbeing among individuals with SCI noted 116 
that most of the evidence to date has been from cross-sectional studies, with little consistency 117 
in the constructs and measures of HRQOL 
20
. Therefore, the aim of this study was to test the 118 
hypothesis that a 6-week home-based upper-body exercise intervention would improve 119 
HRQOL component scores compared to a lifestyle maintenance control group, in persons 120 
with SCI. In keeping with Dijkers 
21
 conceptualisation of HRQOL and supported by previous 121 
research 
10, 20, 22
, it was hypothesized that physical activity behaviour would positively 122 
correlate with objective measures of physical and mental component scores (derived from the 123 
short-form 36 health survey). These summary component scores describe what the individual 124 
can achieve in both the physical and psychological domains.  In addition, and grounded on 125 
the propositions of social cognitive theory 
23
, it was further hypothesized that exercise barrier 126 
self-efficacy would positively correlate with quality of life 
10, 12
.  127 
 128 
METHODS 129 
Study design 130 
This randomised controlled trial (HOMEX-SCI; ISRCTN57096451) was approved by the 131 
National Research Ethics Service Committee. A detailed trial protocol has previously been 132 
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published 
24
 and is in accordance with current Consolidated Standards of Reporting Trials 133 
(CONSORT) guidelines Schulz 
25
. It should be noted that the primary outcome measures 134 
related to biomarkers of cardiometabolic disease are reported elsewhere 
26
. Data reported in 135 
this article are based on the secondary outcome measures associated with HRQOL. 136 
Participants were initially recruited by displaying advertisements on national disability 137 
charity websites, online forums and social media networking sites. Members of our Patient 138 
and Public Involvement (PPI) group, who met the inclusion criteria, were notified directly via 139 
email.  Written informed consent was obtained from all participants. After baseline 140 
laboratory testing and a week of free-living physical activity monitoring, eligible participants 141 
were randomly assigned (2:1 allocation ratio) to a home-based moderate-intensity upper-142 
body exercise intervention (INT), or a lifestyle maintenance control group (CON), for 6 143 
weeks. Minimisation was used to ensure balance between the two groups for baseline 144 
characteristics of; age, body mass, level of spinal cord lesion and physical activity level. All 145 
participants attended the Centre for DisAbility Sport and Health (DASH) laboratory at the 146 
University of Bath, on two occasions, for baseline (week 0) and follow-up testing (week 7). 147 
The same experimental procedures were performed during both baseline and follow-up 148 
testing. It should be noted that we did not plan an intention to treat (ITT) analysis but instead 149 
a treatment exposure analysis (TEA), where only participants that complied with the 150 
intervention were included in the final analyses. 151 
 152 
Sample Size 153 
The sample size was calculated for the primary outcome measure (i.e. fasting serum insulin 154 
concentration), as detailed in the previously published trial protocol 
24
. It was estimated that 155 
nine participants would be required to detect a statistically significant change in insulin 156 
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sensitivity in the INT group, b                      ff      z   C    ’  d) of 1.1. The power 157 
was set at 0.8 and the alpha at 0.05. However, a 2:1 allocation ratio was adopted in 158 
anticipation of more dropouts in the intervention group (INT) compared to the control group 159 
(CON), where there were concerns that by the end of the study the INT group sample might 160 
not be sufficiently large to have adequate power for our planned statistical analyses. 161 
Consequently, a computer programme was used to calculate sample size adjustments for two 162 
groups with unequal size, to account for any consequences of unequal allocation on statistical 163 
power. Also, taking into account an expected drop-out rate of approximately 15%, we aimed 164 
to recruit at least 24 (INT: 16, CON: 8) participants with chronic paraplegia. 165 
 166 
Participants 167 
Participant eligibility criteria were as follows: aged between 18–65 years, inactive (habitual 168 
physical activity level; PAL <1.60); chronic (>1 year) spinal cord lesion below the second 169 
thoracic level; no immediate plans to alter diet and/or physical activity behaviour; weight 170 
stable (±3 kg over the previous 6 months) and; free from active medical issues [i.e. pressure 171 
sores, urinary tract infections and cardiovascular contra-indications for testing] or 172 
musculoskeletal complaints. 173 
 174 
Trial day protocol 175 
Anthropometric characteristics: supine height 
a
 and body mass 
b
 were measured at 0830 ± 1 176 
hr. While participants remained in a 10 hr overnight fast, resting metabolic rate was measured 177 
in a supine position via indirect calorimetry from gaseous exchange 
c
, in accordance with best 178 
practice guidelines 
27
. Participants then completed various HRQOL-related questionnaires: 179 
the short form-36 health survey (SF-3  ;     W          U   ’  S                   180 
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(WUSPI); the Fatigue Severity Scale (FSS) and the Exercise Self-Efficacy Scale (ESES). 181 
These questionnaires were completed, without any time pressures, in a well-lit, private setting 182 
by the participants themselves.  183 
 184 
Participants performed a discontinuous, incremental sub-maximal arm-crank ergometry test 185 
on the same portable desktop ergometer 
d
 provided to them during the intervention. 186 
Following a short rest, p                      2 peak) and workload were measured at the 187 
point of volitional exhaustion during a continuous, incremental exercise protocol 
24
, 188 
performed on an electrically braked arm-crank ergometer 
e
. During both of these exercise 189 
protocols, expired gases were continuously analysed using a calibrated computerised 190 
metabolic system 
f
. Heart rate was also recorded using a heart rate monitor 
g
. 191 
 192 
Objective measurement of physical activity 193 
During the 7-days following baseline laboratory testing, participants wore a chest-mounted 194 
Actiheart
TM
 device 
h
 to estimate free-living habitual physical activity. The Actiheart
TM
 was 195 
individual calibrated for each participant using heart rate data collected at rest and across a 196 
range of exercise intensities during laboratory testing 
24
. This method has been shown to be a 197 
valid measure of physical activity energy expenditure (PAEE) in wheelchair users 
28
. Time 198 
spent performing moderate-to-                            M  A; ≥ 3.0 metabolic 199 
equivalents (METs)], PAL (total energy expenditure/RMR) and absolute PAEE were 200 
estimated. A further 7-day habitual physical activity monitoring period was repeated during 201 
the final week (week 6) of observation, for the INT and CON groups. 202 
 203 
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Home-based moderate-intensity aerobic exercise intervention 204 
The intervention group performed moderate-intensity exercise four times per week on a 205 
portable desktop arm-crank ergometer set up in their own home.                            206 
          f            2 peak            f     3                  2 peak for the final 3-weeks. 207 
To attain the desired exercise intensity, participants wore a Polar T31 heart rate monitor 
g
 208 
during each exercise session and were shown how to manually adjust the resistance to 209 
achieve the prescribed target heart rate. Compliance with the intervention was monitored via 210 
a GENEActiv tri-axial accelerometer 
i
, worn on the wrist, and an activity diary where 211 
participants recorded the difficulty, total revolutions (RPM) and heart-rate during each 212 
exercise session. 213 
 214 
Processing health-related quality of life measures 215 
HRQOL was measured using the SF-36, with data scored using the RAND 36-item Health 216 
survey (Version 1.0) method 
29
. Pre-coded numeric values for each item were transformed 217 
into a score, ranging from 0 to 100, while also accounting for items that were negatively 218 
scored. Items in the same scale were then averaged together to create 8 subscales (four 219 
represent physical quality of life (Physical Component Summary; PCS) and four represent 220 
emotional quality of life (Mental Component Summary; MCS). Using the original SF-36 
30
 in 221 
persons with SCI is not without complications. The rehabilitation research community has 222 
raised concerns about the inclusion of three and two questions that refer to walking and stair 223 
climbing, respectively 
31, 32
. Given that these five physical functioning items are insulting and 224 
irrelevant for persons with SCI,                       ‘    ’     ‘    b’      ‘  ’     ‘   225 
  ’,    previously recommended 33, 34. Construct validity remains acceptable with this 226 
approach 
33
. The SF-36 was also used to derive health utility through the calculation of 227 
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quality adjusted life years (QALY) 
35
. Shoulder pain was measured using the sum of the 15-228 
item WUSPI 
36
. The raw WUSPI score was divided by the number of items completed, then 229 
multiplied by 15 to give the performance-corrected WUSPI score (PC-WUSPI). This was 230 
used to accommodate participants who were unable to undertake certain functions (e.g. item 231 
13: driving?). Fatigue and self-efficacy were also measured using the FSS 
37 
and ESES 
38
, 232 
respectively. 233 
 234 
Outcome measures 235 
A total of seven outcome measures (scale of measurement) were assessed, as follows: 236 
 Physical quality of life (PCS, SF-36) 237 
 Emotional quality of life (MCS, SF-36) 238 
 Quality adjusted life years (QALY) 239 
 Fatigue severity (FSS) 240 
 Global fatigue (FSS Visual Analogue Fatigue Scale) 241 
 Shoulder pain (WUSPI) 242 
 Exercise self-efficacy (ESES). 243 
The main outcome variables of interest were physical quality of life and exercise self-244 
efficacy. Shoulder pain was primarily recorded to assess any changes in shoulder-specific 245 
pain in the intervention group and was not intended as a secondary measure of HRQOL. 246 
 247 
Statistical analyses 248 
Responses within and between trials were analysed by two-way (group [intervention, control] 249 
x time [baseline, follow-up]) mixed-model analysis of variance (ANOVA). ANOVAs were 250 
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performed irrespective of any minor deviations from a normal distribution Maxwell 
39
 but 251 
with Greenhouse-Geisser corrections applied to intra-individual contrasts where ɛ < 0.75 and 252 
the Huynh-Feldt corrections applied for less severe asphericity Atkinson
 40
. Where significant 253 
interaction effects were observed, paired and independent t-tests were applied to determine 254 
significant differences within and between groups. Magnitude-based inferences were used to 255 
provide an interpretation of the real-world relevance of the outcomes 
41
. A value equivalent to 256 
a standardised difference in means of 0.20 was set as the smallest worthwhile effect threshold 257 
42
. Effects were classified as unclear if the percentage likelihood that the true effect crossed 258 
both positive and negative smallest worthwhile effect thresholds were both greater than 5%. 259 
Otherwise, the effect was deemed clear, and was qualified with a probabilistic term using the 260 
following scale: <0.5%, most unlikely; 0.5-5%, very unlikely; 5-25%, unlikely; 25-75%, 261 
possible; 75-95%, likely; 95-99.5%, very likely; >99.5%, most likely 
43
. Standardised effect 262 
sizes (Cohens d) were also calculated, based on the magnitude of correlation between trials, 263 
thresholds of >0.2 (small), >0.5 (moderate) and >0.8 (large) were used
 44
. Pearson product 264 
moment correlation coefficients (r) were conducted on participants who complied with the 265 
intervention (n = 21) to assess the associations between         Δ         f           266 
outcomes (i. . Δ M  A   . Δ  CS).           b        f     Δ                      f   267 
normality of distribution using the Shapiro-Wilk test. Non-parametric Δ        were log-268 
transformed to allow the use of parametric statistics. Data from an ITT analysis (n = 23) is 269 
also presented for comparative purposes (Supplementary Table). Statistical analyses were 270 
performed using SPSS version 22 
j
, with statistical significance set a priori  f α ≤ 0.05. 271 
 272 
RESULTS 273 
Twenty-five participants were recruited into the study between September 2014 and May 274 
2016, with follow-up assessments in a further 8 weeks. One participant was deemed too 275 
13 
 
active at baseline, one participant did not complete the trial due to illness and two participants 276 
were excluded from the analysis due to a lack of adherence to the INT (Figure 1). Baseline 277 
demographic characteristics for the participants included in the treatment-exposure analysis 278 
(n = 21) were; age 47 ± 8 years, time since injury 16 ± 11 years, injury lesion below the T4 279 
level and 71% were male (n = 15). None of these baseline characteristics differed 280 
significantly between groups (P > 0.28). Over the 6-week period mean: subjective ratings of 281 
difficulty for the intervention group sessions was 7 ± 1 (1: easy, 10: hard); exercise session 282 
duration was 44 ± 1 min; power output was 46 ± 18 W and; heart rate was 144 ± 11 b·min
-1
.  283 
 284 
[Insert Figure 1 About Here] 285 
 286 
Participants were asked to eat ad-libitum during the 6-week period and the intervention did 287 
not positively influence body mass relative to                  . W                  288 
     f            .                 ff     f    b                                      M  A 289 
     A   ,                   f           2 peak) and exercise self-efficacy (Table 1). The 290 
standardised effect of the intervention on these outcomes ranged from moderate (d = 0.62) to 291 
large (d = 1.37                    f         f ‘most likely’     ‘very likely’         .   292 
 293 
[Insert Table 1 About Here] 294 
 295 
Intervention effects on health-related quality of life  296 
Changes in PCS were significantly different between the two groups (interaction effect; P = 297 
0.017) with a moderate effect size and a ‘very likely’          inference, in favour of the INT 298 
14 
 
group (Table 1 and Figure 2). There were also trends for an interaction effect in MCS (P = 299 
0.055) and QALY (P = 0.056) with moderate (d = 0.76) and large (d = 0.82) effect sizes, 300 
respectively, for the INT relative to the CON group. The change in the arithmetic mean of the 301 
FSS was significantly different between groups (interaction effect; P = 0.036), with a 302 
significant reduction in the INT group (P = 0.027) (Table 1 and Figure 2). Lower scores on 303 
these 9-items indicate reduced fatigue severity. There was also a trend for an interaction 304 
effect (P = 0.084) in global fatigue measured using the 11-point visual analogue fatigue scale 305 
(VAFS; 0 = worst, 10 = normal). These measures of fatigue demonstrated large effect sizes in 306 
favour of INT (Table 1 and Figure 2). Although there was a small negative effect of INT (d = 307 
-0.35) on shoulder pain, there was no significant interaction (P = 0.386) and the mechanistic 308 
inference was ‘unclear’, suggesting the intervention had no significant or meaningful impact 309 
on perceptions of pain.  310 
 311 
[Insert Figure 2 About Here] 312 
[Insert Figure 3 About Here] 313 
 314 
For comparative purposes, a modified version of Table 1 has been included as a 315 
Supplementary data file. This Table includes data for the two participants that were excluded 316 
due to lack of compliance with the intervention (n=15 for INT group). Had this been a 317 
planned intention to treat (ITT) analysis, these participants would have been included in the 318 
analyses regardless of compliance. While the Tables show small variations in the final effect 319 
size calculations, the main statistical effects and inferences are consistent and robust. The 320 
only noteworthy difference relates to PCS, where the overall effect size is greater, becomes 321 
statistically significant and, in terms of inference, changes from ‘               ’    ‘     322 
               ’                                       . 323 
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Predictors of change in health-related quality of life 324 
Changes in    2 peak were                          Δ M  A  r =  .  ,   =  .  2      Δ 325 
exercise self-efficacy (r = 0.66, P = 0.001). Changes in cardiorespiratory fitness, MVPA and 326 
exercise self-efficacy over the 6 weeks demonstrate moderate to large,      f         ≤  .    327 
associations with changes in various HRQOL outcomes (Table 2).  328 
 329 
[Insert Table 2 About Here]330 
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DISCUSSION 331 
This study investigated the effect of a home-based upper body 6-week exercise intervention 332 
on MVPA, cardiorespiratory fitness (CRF) and indices of HRQOL in people with SCI. The 333 
main findings support our primary hypothesis that a 6-week home-based upper-body exercise 334 
intervention improves aspects of HRQOL in persons with SCI. Furthermore, intervention 335 
induced increases in ESE were positively associated with indicators of both physical and 336 
mental quality of life domains. 337 
 338 
Change in physical activity, cardiorespiratory fitness and exercise self-efficacy 339 
Results revealed that providing an arm-crank ergometer and a personalised progressive 340 
exercise programme increased MVPA and CRF compared to a lifestyle maintenance control 341 
group. These positive effects were observed in a substantially shorter intervention period (i.e. 342 
6-weeks) compared to previous exercise intervention studies in persons with SCI, which were 343 
12 weeks 
45
 and 9 months 
15
, respectively. We also adopted more rigorous methods than those 344 
of Mulroy et al. 
45
, where we used objective measures of MVPA and CRF. In addition, the 345 
intervention had a significant positive effect on participants ESE, that is, people with SCI 346 
who received the intervention demonstrated a significant increase in their perceived 347 
confidence to participate in exercise in the face of barriers such as a lack of access to a gym 348 
or exercise training facilities. Increasing ESE is a key intervention target as it is a modifiable 349 
predictor of physical activity behaviour in a variety of populations 
46, 47
 including people with 350 
SCI 
8-10, 15
.  351 
 352 
Change in health-related quality of life 353 
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The intervention group demonstrated improvements in measures of both physical and 354 
psychological quality of life. Indeed, the measure of physical functioning (PCS) improved 355 
significantly in response to the intervention. Increases in vitality, a measure of how much 356 
energy an individual perceives, was also observed in INT, but not CON (Figure 3). These 357 
findings were coupled with reductions in perceptions of fatigue, adding evidence for the 358 
positive effects of exercise on the physical and psychological quality of life for people with 359 
SCI 
15, 45
. The significant and robust adaptations were observed with no significant effects on 360 
shoulder pain, which is in contrast to previous research where exercise has reduced pain 
11, 45, 
361 
48
. The disparity may be explained by the low levels of shoulder pain reported at baseline 362 
among participants in the current study. Still, the home-based arm-crank ergometry 363 
intervention had positive effects on outcomes such as MVPA, CRF and HRQOL without any 364 
associated increase in shoulder pain. Therefore, this intervention protocol presents a brief, 365 
viable and implementable tool, particularly for those who are exiting intensive rehabilitation 366 
support after SCI and need to transition to independent exercise. 367 
 368 
Despite these beneficial effects, there was only a trend for a significant impact on emotional 369 
quality of life (assessed via the MCS). Dijkers 
21
 conceptualisation of quality of life indicates 370 
that the physical activity - quality of life relationship is driven by achievement domains such 371 
as mental functioning, functional ability and social relationships. It appears that whilst our 372 
intervention improved physical function it did not significantly influence the mental and 373 
social achievement domains. This is not surprising given that the intervention was not 374 
designed to target psychological constructs such as social and mental functioning (i.e. 375 
isolated home-based exercise intervention). Future interventions for people with SCI would 376 
benefit from integrating methods that target improvements in both mental and social 377 
f          . F          ,      b   f                    b               b                   ’  378 
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feelings of autonomy by offering participants choice over the          ’  duration and/or 379 
intensity and support feelings of connectedness with others via virtual or community exercise 380 
groups 
49, 50. H      ,    f             ’   b       o continue exercising in the face of 381 
barriers, which were enhanced in this study, are most relevant when initiating exercise 382 
behaviour 
51
, something this intervention achieved and is important to retain 
52
. 383 
 384 
Although the impact of the intervention on health utility, as measured by QALY, was only 385 
approaching significance, the effect size was large and the inference ‘               ’.     386 
magnitude of this effect is above the threshold to be considered a minimally clinically 387 
important difference (MCID), as previously described by Kaplan 
53
. In addition to targeting 388 
adaptations in social and mental functioning, future interventions should assess health utility 389 
as a primary outcome variable. 390 
  391 
Relationships between changes in physical activity, fitness and health-related quality of 392 
life 393 
A particular strength of this RCT is the ability to investigate relationships between change 394 
scores in objective markers of MVPA and CRF with changes in indices of physical and 395 
psychological quality of life. Results revealed that both MVPA and CRF were significantly 396 
negatively associated with fatigue severity. CRF was also positively related to PCS, MCS and 397 
global fatigue. MVPA was positively associated with QALY, but not with ESE. These 398 
relationships provide credence to the argument that the intervention-induced changes in 399 
MVPA and CRF had a positive impact on            ’                             quality of 400 
life. 401 
 402 
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In addition, CRF was significantly and positively related to change in exercise self-efficacy (r 403 
= 0.66, P = 0.001), which suggests that intervention-induced increases in CRF were 404 
positively associated with            ’  b    f                       f     overcome barriers to 405 
participate in exercise. This is important because ESE has stronger positive associations with 406 
more indices of physical and psychological quality of life than either CRF or MVPA. 407 
Furthermore, ESE is reportedly lower in people with paraplegia who have lower peak power 408 
output 
54
. Therefore, interventions that achieve enhancements in CRF may also achieve a 409 
corresponding enhancement in ESE, physical and psychological quality of life.  410 
 411 
Limitations 412 
Although this intervention demonstrated important and robust effects, the relatively short 413 
duration (i.e. 6 weeks) and lack of follow-up assessments to investigate the longer-term 414 
impact, could be considered limitations. Moreover, the primary power calculation was based 415 
on a physiological outcome variable (i.e. fasting insulin concentration), potentially limiting 416 
the robustness of conclusions made using traditional inferential statistics (mixed-model 417 
ANOVA) on these secondary outcomes. However, standardised effect sizes and magnitude-418 
based inferences were also calculated to help practitioners interpret the real-world relevance 419 
of upper-body exercise on these study outcomes. 420 
 421 
The lack of compliance and subsequent withdrawal of two participants from the analysis 422 
could also be seen as a limitation, although we have been clear that this was a planned 423 
‘                           ’, not an ‘      ion to      ’ analysis. While these participants 424 
were contacted periodically over the 6 weeks, their compliance with exercise duration and/or 425 
intensity was poor. Given the trial design (i.e. remote home-based exercise intervention) this 426 
20 
 
non-compliance only became apparent upon downloading the wearable physical activity 427 
monitors after the post-intervention laboratory testing was completed. Thus, inclusion of 428 
these data could have resulted in erroneous interpretations of the efficacy of the intervention. 429 
Even with the exclusion of these participants, the attrition reported in this current study 430 
(~11%) was considerably less than previous exercise intervention studies conducted in 431 
persons with SCI (~46%) 
55
. Furthermore, the data presented in the supplementary data file 432 
(modified Table 1) include the two ‘        ’ participants and show remarkably similar 433 
effect sizes, statistical outcomes and inferences. Intuitively, the overall effect size for the 434 
physical component score is reduced when these two participants, who did not comply with 435 
the physical intervention, are included in the analysis. 436 
 437 
While the small sample size is also a limitation, researchers should be aware of the 438 
considerable challenges associated with the identification and recruitment of inactive 439 
participants with chronic SCI 
56
. Given the rather large number of statistical tests and 440 
comparisons, we urge caution in the interpretation of effect sizes for individual variables, but 441 
felt that this was more appropriate than reporting an average effect size for a diverse set of 442 
measures of physical and psychological quality of life.  In some cases (i.e. FSS) the 443 
significant interaction effects were possibly reflective of the control group becoming worse 444 
over time. We wish to point out that Post Hoc analyses (within group paired t-tests) revealed 445 
statistically significant ‘improvements’ in the intervention group and no statistical significant 446 
changes over time in the control group. Nevertheless, it is important to emphasise that being 447 
randomly allocated to the control group may have detrimental effects on participants, an 448 
observation which is consistent with findings from other exercise RCTs in this population 
15
. 449 
This trial employed a waiting list control 
24
    f                                 ‘    -     ’ 450 
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control group. However, perhaps other innovative solutions are required in the future to 451 
overcome such issues.   452 
 453 
Implications and future directions  454 
This home-based exercise intervention for inactive people with a SCI overcame known 455 
  f             . . ‘      f          ’, ‘      f          ’                         i.e. 456 
‘       b     ’, ‘f             ’  barriers 17-19, 57 and was effective at initiating MVPA 457 
sufficient to improve objective physical and psychological quality of life. Therefore, this 458 
programme could be implemented to bridge the gap between intensive supervised 459 
rehabilitation and independent exercise. Moreover, the SF-36 is one of the most widely 460 
employed measures of physical and psychological quality of life in the general population as 461 
well as in SCI and has been shown to be sensitive to changes in physical activity 
58
. This 462 
study did not observe intervention effects for MCS, which includes social functioning and 463 
mental health subscales of the SF-36. Modifications could be made to the intervention to 464 
target these domains in order to maximise the beneficial outcomes. Future research could 465 
supplement this brief intervention with empirically-informed design and delivery to support 466 
adherence and maintenance to exercise regimes 
59, 60
, factors that can inhibit the efficacy of 467 
exercise interventions
 61
. Such investigations would help to inform effective methods of 468 
supporting persons with SCI transition to physically active lifestyles following intensive 469 
clinical rehabilitation.    470 
 471 
CONCLUSION   472 
This short home-based upper-body exercise intervention is an effective way of enhancing 473 
indices of physical and psychological quality of life in people with SCI. Exercise self-474 
22 
 
efficacy was a prominent outcome from the intervention, demonstrating stronger associations 475 
with more indices of physical and psychological quality of life than either MVPA or CRF.  476 
Future research should supplement this intervention with empirically-informed trial designs 477 
to support social and mental functioning, adaptive motivations and exercise maintenance.  478 
 479 
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Figure Legends 1 
 2 
 3 
Figure 1. Consolidated Standards of Reporting Trials (CONSORT) flow diagram for 4 
HOMEX-SCI trial. 5 
 6 
Figure 2. SF-36, physical component summary
1
 (A) and mental component summary
1
 (B); 7 
and arithmetic fatigue severity mean
2
 (C) and global fatigue
3 
(D) at baseline and follow-up 8 
for the INT (solid black line and open diamond) and CON (dashed line and black triangle) 9 
groups. Means ± normalised confidence intervals (CIs) are shown. There were no significant 10 
  ff           b           ≥  .1 9  b             . P values are displayed for significant day 11 
x group interaction effects. # denotes values are different pre-                         ≤ 12 
0.05).  13 
1 
scaled summaries from the SF-36 questionnaire (higher scores indicate a more favourable 14 
health state). 15 
2
 arithmetic mean from 9-item FSS (7 point scale; 1 = strongly disagree, 7 = strongly agree). 16 
Higher scores indicate greater fatigue severity, with cut-scores over 4 indicative of 17 
significant fatigue 
62
. 18 
3 
global fatigue from FSS (11 point visual analogue fatigue scale (VAFS); 0 = worst, 10 = 19 
normal). 20 
 21 
Figure 3: Standardised effect sizes (Cohens d) (±90% CI) and magnitude based inferences 22 
for all health related quality of life outcomes.  23 
1 
SF-36, 
2 
Fatigue severity scale, 
3 
Wheelchair user shoulder pain index. 24 
‡ D          f  ff                        F      f              . A              f    9-item 25 
FSS went down, which indicates reduced fatigue severity. 26 
Abbreviations: CON, lifestyle maintenance control group; INT, upper-body exercise 27 
intervention; MCS, mental component summary; PCS, physical component summary, QALY, 28 
quality-adjusted life years. 29 
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Abstract 21 
Objective: To assess the influence of a home-based exercise intervention on indices of 22 
health-related quality of life (HRQOL) in persons with spinal cord injury (SCI). 23 
Design: This was a randomized controlled trial (HOMEX-SCI; ISRCTN57096451). After 24 
baseline laboratory testing and a week of free-living physical activity monitoring, eligible 25 
participants were randomly assigned (2:1 allocation ratio) to a home-based moderate-26 
intensity upper-body exercise intervention (INT, n = 13), or a lifestyle maintenance control 27 
group (CON, n = 8), for 6 weeks. 28 
Setting: Home-based with short laboratory visits immediately before and after the 29 
intervention/control period. 30 
Participants: Twenty-one inactive participants with chronic (> 1 year) SCI (injury level 31 
range, T4 – L5). 32 
Intervention:                                                                              33 
               -             -                           2 peak]) arm-crank exercise per 34 
week for 6 weeks. Participants assigned to the control group (CON) were asked to maintain 35 
their habitual physical activity behaviour. 36 
Main Outcome Measures: Secondary outcome measures were assessed, including physical 37 
and emotional component scores (PCS and MCS) of health-related quality of life (SF-36), 38 
fatigue, global fatigue (FSS) and shoulder pain index (WUSPI). Cardiorespiratory fitness 39 
(CRF), objectively measured habitual moderate-to-vigorous physical activity (MVPA) and 40 
exercise self-efficacy (ESE) were also assessed at baseline and follow-up. 41 
Results. Changes in the PCS (P = 0.017) of the SF-36, ESE (P = 0.011) and FSS (P = 0.036) 42 
were significantly different between the two groups, with moderate to large effect sizes (d = 43 
3 
 
0.75 – 1.37 .         HRQ L                       ‘      ’    ‘           ’          44 
inferences in favour of the INT group following the 6-week exercise intervention. Changes in 45 
ESE were significantly (P < 0.01) associated with changes in PCS (r = 0.62) and MCS (r = 46 
0.71), FSS (r = -0.71) and global fatigue (r = 0.57). 47 
Conclusions. A 6-week upper-body exercise intervention improved indices of HRQOL in 48 
persons with SCI. Improvements were associated with increases in ESE. While this 49 
intervention demonstrated a positive impact on perceived physical functioning, future 50 
interventions should aim to support social and mental functioning and exercise maintenance. 51 
 52 
Key words: Spinal cord injury; exercise intervention; health and wellbeing; self efficacy; 53 
quality of life 54 
 55 
 56 
 57 
 58 
 59 
 60 
 61 
 62 
 63 
 64 
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Abbreviations: 65 
CON- Lifestyle maintenance control group, 66 
ESE- Exercise Self-Efficacy 67 
ESES- Exercise Self-Efficacy Scale 68 
FSS- fatigue severity scale 69 
HOMEX-SCI- Home-based upper-body exercise randomized controlled trial, 70 
HRQOL- Health-related quality of life 71 
INT- Home-based moderate-intensity upper-body exercise intervention group, 72 
MVPA- moderate-to-vigorous physical activity, 73 
SCI- spinal cord injury, 74 
SF36- short form 36 health survey, 75 
CRF- cardiorespiratory fitness, 76 
   2peak - peak oxygen uptake, 77 
WUSPI- wheelchair user shoulder pain index 78 
 79 
 80 
 81 
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INTRODUCTION 85 
Disability can negatively impact physical activity behaviour 
1
. The reasons for the adoption 86 
of a more sedentary lifestyle are multifactorial, but the perceived psychosocial and 87 
environmental barriers to engage in physical activity are numerous for wheelchair users 88 
living with a spinal cord injury (SCI) 
2, 3
. Consequently, persons with SCI are relatively 89 
inactive 
4 
and new ways to support the initiation of physical activity in this population are 90 
needed. 91 
Besides an increased incidence of chronic diseases (e.g. cardiovascular disease, type 2 92 
diabetes) 
5
, persons with SCI have significantly elevated levels of fatigue, anxiety, depression 93 
and poorer exercise self-efficacy (ESE) compared to non-disabled controls 
6, 7
. This is 94 
important because physical activity can improve quality of life for people with SCI and ESE 95 
is considered a modifiable predictor of physical activity behaviour change, specifically in this 96 
population 
8-12
. Therefore, it is essential to develop strategies capable of improving exercise 97 
self-efficacy in order to increase physical activity participation and accrue enhancements in 98 
quality of life.  99 
Educational interventions, covering physical activity, nutrition and lifestyle management, 100 
have been shown to improve exercise self-efficacy and self-rated health, and result in fewer 101 
and less severe secondary conditions in persons with SCI 
13, 14
. Following a 9-month, twice-102 
weekly strength and arm-ergometry intervention, participants reported significantly higher 103 
levels of satisfaction with physical function, level of perceived health, overall quality of life 104 
and less pain than a control group 
15
. However, these findings have not been demonstrated 105 
with shorter term, higher volume aerobic exercise training per se. Moreover, it has previously 106 
been suggested that upper-body exercise, primarily arm-crank ergometry as a training 107 
modality, might contribute to shoulder overuse injuries and trigger the onset of pain 
16
. 108 
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Therefore, the available evidence is currently inconclusive about whether upper-body arm-109 
crank exercise is an effective treatment modality for improving health-related quality of life 110 
(HRQOL) in persons with SCI. Furthermore, a lack of access to gym facilities and exercise 111 
equipment, as well as poor information and support, have been identified as key barriers to 112 
exercise for adults with SCI 17-19. Therefore, the provision of exercise equipment and a 113 
tailored exercise programme within a home setting could provide a mastery experience and 114 
help enhance ESE in people with SCI.  115 
A recent meta-analysis on physical activity and wellbeing among individuals with SCI noted 116 
that most of the evidence to date has been from cross-sectional studies, with little consistency 117 
in the constructs and measures of HRQOL 
20
. Therefore, the aim of this study was to test the 118 
hypothesis that a 6-week home-based upper-body exercise intervention would improve 119 
HRQOL component scores compared to a lifestyle maintenance control group, in persons 120 
with SCI. In keeping with Dijkers 
21
 conceptualisation of HRQOL and supported by previous 121 
research 
10, 20, 22
, it was hypothesized that physical activity behaviour would positively 122 
correlate with objective measures of physical and mental component scores (derived from the 123 
short-form 36 health survey). These summary component scores describe what the individual 124 
can achieve in both the physical and psychological domains.  In addition, and grounded on 125 
the propositions of social cognitive theory 
23
, it was further hypothesized that exercise barrier 126 
self-efficacy would positively correlate with quality of life 
10, 12
.  127 
 128 
METHODS 129 
Study design 130 
This randomised controlled trial (HOMEX-SCI; ISRCTN57096451) was approved by the 131 
National Research Ethics Service Committee. A detailed trial protocol has previously been 132 
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published 
24
 and is in accordance with current Consolidated Standards of Reporting Trials 133 
(CONSORT) guidelines Schulz 
25
. It should be noted that the primary outcome measures 134 
related to biomarkers of cardiometabolic disease are reported elsewhere 
26
. Data reported in 135 
this article are based on the secondary outcome measures associated with HRQOL. 136 
Participants were initially recruited by displaying advertisements on national disability 137 
charity websites, online forums and social media networking sites. Members of our Patient 138 
and Public Involvement (PPI) group, who met the inclusion criteria, were notified directly via 139 
email.  Written informed consent was obtained from all participants. After baseline 140 
laboratory testing and a week of free-living physical activity monitoring, eligible participants 141 
were randomly assigned (2:1 allocation ratio) to a home-based moderate-intensity upper-142 
body exercise intervention (INT), or a lifestyle maintenance control group (CON), for 6 143 
weeks. Minimisation was used to ensure balance between the two groups for baseline 144 
characteristics of; age, body mass, level of spinal cord lesion and physical activity level. All 145 
participants attended the Centre for DisAbility Sport and Health (DASH) laboratory at the 146 
University of Bath, on two occasions, for baseline (week 0) and follow-up testing (week 7). 147 
The same experimental procedures were performed during both baseline and follow-up 148 
testing. It should be noted that we did not plan an intention to treat (ITT) analysis but instead 149 
a treatment exposure analysis (TEA), where only participants that complied with the 150 
intervention were included in the final analyses. 151 
 152 
Sample Size 153 
The sample size was calculated for the primary outcome measure (i.e. fasting serum insulin 154 
concentration), as detailed in the previously published trial protocol 
24
. It was estimated that 155 
nine participants would be required to detect a statistically significant change in insulin 156 
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sensitivity in the INT group, b                      ff      z   C    ’  d) of 1.1. The power 157 
was set at 0.8 and the alpha at 0.05. However, a 2:1 allocation ratio was adopted in 158 
anticipation of more dropouts in the intervention group (INT) compared to the control group 159 
(CON), where there were concerns that by the end of the study the INT group sample might 160 
not be sufficiently large to have adequate power for our planned statistical analyses. 161 
Consequently, a computer programme was used to calculate sample size adjustments for two 162 
groups with unequal size, to account for any consequences of unequal allocation on statistical 163 
power. Also, taking into account an expected drop-out rate of approximately 15%, we aimed 164 
to recruit at least 24 (INT: 16, CON: 8) participants with chronic paraplegia. 165 
 166 
Participants 167 
Participant eligibility criteria were as follows: aged between 18–65 years, inactive (habitual 168 
physical activity level; PAL <1.60); chronic (>1 year) spinal cord lesion below the second 169 
thoracic level; no immediate plans to alter diet and/or physical activity behaviour; weight 170 
stable (±3 kg over the previous 6 months) and; free from active medical issues [i.e. pressure 171 
sores, urinary tract infections and cardiovascular contra-indications for testing] or 172 
musculoskeletal complaints. 173 
 174 
Trial day protocol 175 
Anthropometric characteristics: supine height 
a
 and body mass 
b
 were measured at 0830 ± 1 176 
hr. While participants remained in a 10 hr overnight fast, resting metabolic rate was measured 177 
in a supine position via indirect calorimetry from gaseous exchange 
c
, in accordance with best 178 
practice guidelines 
27
. Participants then completed various HRQOL-related questionnaires: 179 
the short form-36 health survey (SF-3  ;     W          U   ’  S                   180 
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(WUSPI); the Fatigue Severity Scale (FSS) and the Exercise Self-Efficacy Scale (ESES). 181 
These questionnaires were completed, without any time pressures, in a well-lit, private setting 182 
by the participants themselves.  183 
 184 
Participants performed a discontinuous, incremental sub-maximal arm-crank ergometry test 185 
on the same portable desktop ergometer 
d
 provided to them during the intervention. 186 
Following a short rest, p                      2 peak) and workload were measured at the 187 
point of volitional exhaustion during a continuous, incremental exercise protocol 
24
, 188 
performed on an electrically braked arm-crank ergometer 
e
. During both of these exercise 189 
protocols, expired gases were continuously analysed using a calibrated computerised 190 
metabolic system 
f
. Heart rate was also recorded using a heart rate monitor 
g
. 191 
 192 
Objective measurement of physical activity 193 
During the 7-days following baseline laboratory testing, participants wore a chest-mounted 194 
Actiheart
TM
 device 
h
 to estimate free-living habitual physical activity. The Actiheart
TM
 was 195 
individual calibrated for each participant using heart rate data collected at rest and across a 196 
range of exercise intensities during laboratory testing 
24
. This method has been shown to be a 197 
valid measure of physical activity energy expenditure (PAEE) in wheelchair users 
28
. Time 198 
spent performing moderate-to-                            M  A; ≥ 3.0 metabolic 199 
equivalents (METs)], PAL (total energy expenditure/RMR) and absolute PAEE were 200 
estimated. A further 7-day habitual physical activity monitoring period was repeated during 201 
the final week (week 6) of observation, for the INT and CON groups. 202 
 203 
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Home-based moderate-intensity aerobic exercise intervention 204 
The intervention group performed moderate-intensity exercise four times per week on a 205 
portable desktop arm-crank ergometer set up in their own home.                            206 
          f            2 peak            f     3                  2 peak for the final 3-weeks. 207 
To attain the desired exercise intensity, participants wore a Polar T31 heart rate monitor 
g
 208 
during each exercise session and were shown how to manually adjust the resistance to 209 
achieve the prescribed target heart rate. Compliance with the intervention was monitored via 210 
a GENEActiv tri-axial accelerometer 
i
, worn on the wrist, and an activity diary where 211 
participants recorded the difficulty, total revolutions (RPM) and heart-rate during each 212 
exercise session. 213 
 214 
Processing health-related quality of life measures 215 
HRQOL was measured using the SF-36, with data scored using the RAND 36-item Health 216 
survey (Version 1.0) method 
29
. Pre-coded numeric values for each item were transformed 217 
into a score, ranging from 0 to 100, while also accounting for items that were negatively 218 
scored. Items in the same scale were then averaged together to create 8 subscales (four 219 
represent physical quality of life (Physical Component Summary; PCS) and four represent 220 
emotional quality of life (Mental Component Summary; MCS). Using the original SF-36 
30
 in 221 
persons with SCI is not without complications. The rehabilitation research community has 222 
raised concerns about the inclusion of three and two questions that refer to walking and stair 223 
climbing, respectively 
31, 32
. Given that these five physical functioning items are insulting and 224 
irrelevant for persons with SCI, we replaced the wor   ‘    ’     ‘    b’      ‘  ’     ‘   225 
  ’,    previously recommended 33, 34. Construct validity remains acceptable with this 226 
approach 
33
. The SF-36 was also used to derive health utility through the calculation of 227 
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quality adjusted life years (QALY) 
35
. Shoulder pain was measured using the sum of the 15-228 
item WUSPI 
36
. The raw WUSPI score was divided by the number of items completed, then 229 
multiplied by 15 to give the performance-corrected WUSPI score (PC-WUSPI). This was 230 
used to accommodate participants who were unable to undertake certain functions (e.g. item 231 
13: driving?). Fatigue and self-efficacy were also measured using the FSS 
37 
and ESES 
38
, 232 
respectively. 233 
 234 
Outcome measures 235 
A total of seven outcome measures (scale of measurement) were assessed, as follows: 236 
 Physical quality of life (PCS, SF-36) 237 
 Emotional quality of life (MCS, SF-36) 238 
 Quality adjusted life years (QALY) 239 
 Fatigue severity (FSS) 240 
 Global fatigue (FSS Visual Analogue Fatigue Scale) 241 
 Shoulder pain (WUSPI) 242 
 Exercise self-efficacy (ESES). 243 
The main outcome variables of interest were physical quality of life and exercise self-244 
efficacy. Shoulder pain was primarily recorded to assess any changes in shoulder-specific 245 
pain in the intervention group and was not intended as a secondary measure of HRQOL. 246 
 247 
Statistical analyses 248 
Responses within and between trials were analysed by two-way (group [intervention, control] 249 
x time [baseline, follow-up]) mixed-model analysis of variance (ANOVA). ANOVAs were 250 
12 
 
performed irrespective of any minor deviations from a normal distribution Maxwell 
39
 but 251 
with Greenhouse-Geisser corrections applied to intra-individual contrasts where ɛ < 0.75 and 252 
the Huynh-Feldt corrections applied for less severe asphericity Atkinson
 40
. Where significant 253 
interaction effects were observed, paired and independent t-tests were applied to determine 254 
significant differences within and between groups. Magnitude-based inferences were used to 255 
provide an interpretation of the real-world relevance of the outcomes 
41
. A value equivalent to 256 
a standardised difference in means of 0.20 was set as the smallest worthwhile effect threshold 257 
42
. Effects were classified as unclear if the percentage likelihood that the true effect crossed 258 
both positive and negative smallest worthwhile effect thresholds were both greater than 5%. 259 
Otherwise, the effect was deemed clear, and was qualified with a probabilistic term using the 260 
following scale: <0.5%, most unlikely; 0.5-5%, very unlikely; 5-25%, unlikely; 25-75%, 261 
possible; 75-95%, likely; 95-99.5%, very likely; >99.5%, most likely 
43
. Standardised effect 262 
sizes (Cohens d) were also calculated, based on the magnitude of correlation between trials, 263 
thresholds of >0.2 (small), >0.5 (moderate) and >0.8 (large) were used
 44
. Pearson product 264 
moment correlation coefficients (r) were conducted on participants who complied with the 265 
intervention (n = 21) to assess the associations between         Δ         f           266 
outcomes (i. . Δ M  A   . Δ  CS).           b        f     Δ                      f   267 
normality of distribution using the Shapiro-Wilk test. Non-parametric Δ        were log-268 
transformed to allow the use of parametric statistics. Data from an ITT analysis (n = 23) is 269 
also presented for comparative purposes (Supplementary Table). Statistical analyses were 270 
performed using SPSS version 22 
j
, with statistical significance set a priori  f α ≤ 0.05. 271 
 272 
RESULTS 273 
Twenty-five participants were recruited into the study between September 2014 and May 274 
2016, with follow-up assessments in a further 8 weeks. One participant was deemed too 275 
13 
 
active at baseline, one participant did not complete the trial due to illness and two participants 276 
were excluded from the analysis due to a lack of adherence to the INT (Figure 1). Baseline 277 
demographic characteristics for the participants included in the treatment-exposure analysis 278 
(n = 21) were; age 47 ± 8 years, time since injury 16 ± 11 years, injury lesion below the T4 279 
level and 71% were male (n = 15). None of these baseline characteristics differed 280 
significantly between groups (P > 0.28). Over the 6-week period mean: subjective ratings of 281 
difficulty for the intervention group sessions was 7 ± 1 (1: easy, 10: hard); exercise session 282 
duration was 44 ± 1 min; power output was 46 ± 18 W and; heart rate was 144 ± 11 b·min
-1
.  283 
 284 
[Insert Figure 1 About Here] 285 
 286 
Participants were asked to eat ad-libitum during the 6-week period and the intervention did 287 
not positively influence body mass relative to                  . W                  288 
     f            .                 ff     f    b                                      M  A 289 
     A   ,                   f           2 peak) and exercise self-efficacy (Table 1). The 290 
standardised effect of the intervention on these outcomes ranged from moderate (d = 0.62) to 291 
large (d = 1.37                    f         f ‘most likely’     ‘very likely’         .   292 
 293 
[Insert Table 1 About Here] 294 
 295 
Intervention effects on health-related quality of life  296 
Changes in PCS were significantly different between the two groups (interaction effect; P = 297 
0.017) with a moderate effect size and a ‘very likely’          inference, in favour of the INT 298 
14 
 
group (Table 1 and Figure 2). There were also trends for an interaction effect in MCS (P = 299 
0.055) and QALY (P = 0.056) with moderate (d = 0.76) and large (d = 0.82) effect sizes, 300 
respectively, for the INT relative to the CON group. The change in the arithmetic mean of the 301 
FSS was significantly different between groups (interaction effect; P = 0.036), with a 302 
significant reduction in the INT group (P = 0.027) (Table 1 and Figure 2). Lower scores on 303 
these 9-items indicate reduced fatigue severity. There was also a trend for an interaction 304 
effect (P = 0.084) in global fatigue measured using the 11-point visual analogue fatigue scale 305 
(VAFS; 0 = worst, 10 = normal). These measures of fatigue demonstrated large effect sizes in 306 
favour of INT (Table 1 and Figure 2). Although there was a small negative effect of INT (d = 307 
-0.35) on shoulder pain, there was no significant interaction (P = 0.386) and the mechanistic 308 
inference was ‘unclear’, suggesting the intervention had no significant or meaningful impact 309 
on perceptions of pain.  310 
 311 
[Insert Figure 2 About Here] 312 
[Insert Figure 3 About Here] 313 
 314 
For comparative purposes, a modified version of Table 1 has been included as a 315 
Supplementary data file. This Table includes data for the two participants that were excluded 316 
due to lack of compliance with the intervention (n=15 for INT group). Had this been a 317 
planned intention to treat (ITT) analysis, these participants would have been included in the 318 
analyses regardless of compliance. While the Tables show small variations in the final effect 319 
size calculations, the main statistical effects and inferences are consistent and robust. The 320 
only noteworthy difference relates to PCS, where the overall effect size is greater, becomes 321 
statistically significant and, in terms of inference, changes from ‘               ’    ‘     322 
               ’                                       . 323 
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Predictors of change in health-related quality of life 324 
Changes in    2 peak were                          Δ M  A  r =  .  ,   =  .  2      Δ 325 
exercise self-efficacy (r = 0.66, P = 0.001). Changes in cardiorespiratory fitness, MVPA and 326 
exercise self-efficacy over the 6 weeks demonstrate moderate to large,      f         ≤  .    327 
associations with changes in various HRQOL outcomes (Table 2).  328 
 329 
[Insert Table 2 About Here]330 
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DISCUSSION 331 
This study investigated the effect of a home-based upper body 6-week exercise intervention 332 
on MVPA, cardiorespiratory fitness (CRF) and indices of HRQOL in people with SCI. The 333 
main findings support our primary hypothesis that a 6-week home-based upper-body exercise 334 
intervention improves aspects of HRQOL in persons with SCI. Furthermore, intervention 335 
induced increases in ESE were positively associated with indicators of both physical and 336 
mental quality of life domains. 337 
 338 
Change in physical activity, cardiorespiratory fitness and exercise self-efficacy 339 
Results revealed that providing an arm-crank ergometer and a personalised progressive 340 
exercise programme increased MVPA and CRF compared to a lifestyle maintenance control 341 
group. These positive effects were observed in a substantially shorter intervention period (i.e. 342 
6-weeks) compared to previous exercise intervention studies in persons with SCI, which were 343 
12 weeks 
45
 and 9 months 
15
, respectively. We also adopted more rigorous methods than those 344 
of Mulroy et al. 
45
, where we used objective measures of MVPA and CRF. In addition, the 345 
intervention had a significant positive effect on participants ESE, that is, people with SCI 346 
who received the intervention demonstrated a significant increase in their perceived 347 
confidence to participate in exercise in the face of barriers such as a lack of access to a gym 348 
or exercise training facilities. Increasing ESE is a key intervention target as it is a modifiable 349 
predictor of physical activity behaviour in a variety of populations 
46, 47
 including people with 350 
SCI 
8-10, 15
.  351 
 352 
Change in health-related quality of life 353 
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The intervention group demonstrated improvements in measures of both physical and 354 
psychological quality of life. Indeed, the measure of physical functioning (PCS) improved 355 
significantly in response to the intervention. Increases in vitality, a measure of how much 356 
energy an individual perceives, was also observed in INT, but not CON (Figure 3). These 357 
findings were coupled with reductions in perceptions of fatigue, adding evidence for the 358 
positive effects of exercise on the physical and psychological quality of life for people with 359 
SCI 
15, 45
. The significant and robust adaptations were observed with no significant effects on 360 
shoulder pain, which is in contrast to previous research where exercise has reduced pain 
11, 45, 
361 
48
. The disparity may be explained by the low levels of shoulder pain reported at baseline 362 
among participants in the current study. Still, the home-based arm-crank ergometry 363 
intervention had positive effects on outcomes such as MVPA, CRF and HRQOL without any 364 
associated increase in shoulder pain. Therefore, this intervention protocol presents a brief, 365 
viable and implementable tool, particularly for those who are exiting intensive rehabilitation 366 
support after SCI and need to transition to independent exercise. 367 
 368 
Despite these beneficial effects, there was only a trend for a significant impact on emotional 369 
quality of life (assessed via the MCS). Dijkers 
21
 conceptualisation of quality of life indicates 370 
that the physical activity - quality of life relationship is driven by achievement domains such 371 
as mental functioning, functional ability and social relationships. It appears that whilst our 372 
intervention improved physical function it did not significantly influence the mental and 373 
social achievement domains. This is not surprising given that the intervention was not 374 
designed to target psychological constructs such as social and mental functioning (i.e. 375 
isolated home-based exercise intervention). Future interventions for people with SCI would 376 
benefit from integrating methods that target improvements in both mental and social 377 
f          . F          ,      b   f                    b               b                   ’  378 
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feelings of autonomy by offering participants choice over the          ’  duration and/or 379 
intensity and support feelings of connectedness with others via virtual or community exercise 380 
groups 
49, 50. H      ,    f             ’   b                                    f     f 381 
barriers, which were enhanced in this study, are most relevant when initiating exercise 382 
behaviour 
51
, something this intervention achieved and is important to retain 
52
. 383 
 384 
Although the impact of the intervention on health utility, as measured by QALY, was only 385 
approaching significance, the effect size was large and the inference ‘               ’.     386 
magnitude of this effect is above the threshold to be considered a minimally clinically 387 
important difference (MCID), as previously described by Kaplan 
53
. In addition to targeting 388 
adaptations in social and mental functioning, future interventions should assess health utility 389 
as a primary outcome variable. 390 
  391 
Relationships between changes in physical activity, fitness and health-related quality of 392 
life 393 
A particular strength of this RCT is the ability to investigate relationships between change 394 
scores in objective markers of MVPA and CRF with changes in indices of physical and 395 
psychological quality of life. Results revealed that both MVPA and CRF were significantly 396 
negatively associated with fatigue severity. CRF was also positively related to PCS, MCS and 397 
global fatigue. MVPA was positively associated with QALY, but not with ESE. These 398 
relationships provide credence to the argument that the intervention-induced changes in 399 
MVPA and CRF had a positive impact on            ’                             quality of 400 
life. 401 
 402 
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In addition, CRF was significantly and positively related to change in exercise self-efficacy (r 403 
= 0.66, P = 0.001), which suggests that intervention-induced increases in CRF were 404 
positively associated with            ’  b    f                       f     overcome barriers to 405 
participate in exercise. This is important because ESE has stronger positive associations with 406 
more indices of physical and psychological quality of life than either CRF or MVPA. 407 
Furthermore, ESE is reportedly lower in people with paraplegia who have lower peak power 408 
output 
54
. Therefore, interventions that achieve enhancements in CRF may also achieve a 409 
corresponding enhancement in ESE, physical and psychological quality of life.  410 
 411 
Limitations 412 
Although this intervention demonstrated important and robust effects, the relatively short 413 
duration (i.e. 6 weeks) and lack of follow-up assessments to investigate the longer-term 414 
impact, could be considered limitations. Moreover, the primary power calculation was based 415 
on a physiological outcome variable (i.e. fasting insulin concentration), potentially limiting 416 
the robustness of conclusions made using traditional inferential statistics (mixed-model 417 
ANOVA) on these secondary outcomes. However, standardised effect sizes and magnitude-418 
based inferences were also calculated to help practitioners interpret the real-world relevance 419 
of upper-body exercise on these study outcomes. 420 
 421 
The lack of compliance and subsequent withdrawal of two participants from the analysis 422 
could also be seen as a limitation, although we have been clear that this was a planned 423 
‘                           ’, not an ‘      ion to      ’ analysis. While these participants 424 
were contacted periodically over the 6 weeks, their compliance with exercise duration and/or 425 
intensity was poor. Given the trial design (i.e. remote home-based exercise intervention) this 426 
20 
 
non-compliance only became apparent upon downloading the wearable physical activity 427 
monitors after the post-intervention laboratory testing was completed. Thus, inclusion of 428 
these data could have resulted in erroneous interpretations of the efficacy of the intervention. 429 
Even with the exclusion of these participants, the attrition reported in this current study 430 
(~11%) was considerably less than previous exercise intervention studies conducted in 431 
persons with SCI (~46%) 
55
. Furthermore, the data presented in the supplementary data file 432 
(modified Table 1) include the two ‘        ’ participants and show remarkably similar 433 
effect sizes, statistical outcomes and inferences. Intuitively, the overall effect size for the 434 
physical component score is reduced when these two participants, who did not comply with 435 
the physical intervention, are included in the analysis. 436 
 437 
While the small sample size is also a limitation, researchers should be aware of the 438 
considerable challenges associated with the identification and recruitment of inactive 439 
participants with chronic SCI 
56
. Given the rather large number of statistical tests and 440 
comparisons, we urge caution in the interpretation of effect sizes for individual variables, but 441 
felt that this was more appropriate than reporting an average effect size for a diverse set of 442 
measures of physical and psychological quality of life.  In some cases (i.e. FSS) the 443 
significant interaction effects were possibly reflective of the control group becoming worse 444 
over time. We wish to point out that Post Hoc analyses (within group paired t-tests) revealed 445 
statistically significant ‘improvements’ in the intervention group and no statistical significant 446 
changes over time in the control group. Nevertheless, it is important to emphasise that being 447 
randomly allocated to the control group may have detrimental effects on participants, an 448 
observation which is consistent with findings from other exercise RCTs in this population 
15
. 449 
This trial employed a waiting list control 
24
    f                                 ‘    -     ’ 450 
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control group. However, perhaps other innovative solutions are required in the future to 451 
overcome such issues.   452 
 453 
Implications and future directions  454 
This home-based exercise intervention for inactive people with a SCI overcame known 455 
  f             . . ‘      f          ’, ‘      f          ’                         i.e. 456 
‘       b     ’, ‘f             ’  barriers 17-19, 57 and was effective at initiating MVPA 457 
sufficient to improve objective physical and psychological quality of life. Therefore, this 458 
programme could be implemented to bridge the gap between intensive supervised 459 
rehabilitation and independent exercise. Moreover, the SF-36 is one of the most widely 460 
employed measures of physical and psychological quality of life in the general population as 461 
well as in SCI and has been shown to be sensitive to changes in physical activity 
58
. This 462 
study did not observe intervention effects for MCS, which includes social functioning and 463 
mental health subscales of the SF-36. Modifications could be made to the intervention to 464 
target these domains in order to maximise the beneficial outcomes. Future research could 465 
supplement this brief intervention with empirically-informed design and delivery to support 466 
adherence and maintenance to exercise regimes 
59, 60
, factors that can inhibit the efficacy of 467 
exercise interventions
 61
. Such investigations would help to inform effective methods of 468 
supporting persons with SCI transition to physically active lifestyles following intensive 469 
clinical rehabilitation.    470 
 471 
CONCLUSION   472 
This short home-based upper-body exercise intervention is an effective way of enhancing 473 
indices of physical and psychological quality of life in people with SCI. Exercise self-474 
22 
 
efficacy was a prominent outcome from the intervention, demonstrating stronger associations 475 
with more indices of physical and psychological quality of life than either MVPA or CRF.  476 
Future research should supplement this intervention with empirically-informed trial designs 477 
to support social and mental functioning, adaptive motivations and exercise maintenance.  478 
 479 
 480 
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Figure Legends 1 
 2 
 3 
Figure 1. Consolidated Standards of Reporting Trials (CONSORT) flow diagram for 4 
HOMEX-SCI trial. 5 
 6 
Figure 2. SF-36, physical component summary
1
 (A) and mental component summary
1
 (B); 7 
and arithmetic fatigue severity mean
2
 (C) and global fatigue
3 
(D) at baseline and follow-up 8 
for the INT (solid black line and open diamond) and CON (dashed line and black triangle) 9 
groups. Means ± normalised confidence intervals (CIs) are shown. There were no significant 10 
  ff           b           ≥  .1 9  b             . P values are displayed for significant day 11 
x group interaction effects. # denotes values are different pre-                         ≤ 12 
0.05).  13 
1 
scaled summaries from the SF-36 questionnaire (higher scores indicate a more favourable 14 
health state). 15 
2
 arithmetic mean from 9-item FSS (7 point scale; 1 = strongly disagree, 7 = strongly agree). 16 
Higher scores indicate greater fatigue severity, with cut-scores over 4 indicative of 17 
significant fatigue 
62
. 18 
3 
global fatigue from FSS (11 point visual analogue fatigue scale (VAFS); 0 = worst, 10 = 19 
normal). 20 
 21 
Figure 3: Standardised effect sizes (Cohens d) (±90% CI) and magnitude based inferences 22 
for all health related quality of life outcomes.  23 
1 
SF-36, 
2 
Fatigue severity scale, 
3 
Wheelchair user shoulder pain index. 24 
‡ D          f  ff                        F      f              . A              f    9-item 25 
FSS went down, which indicates reduced fatigue severity. 26 
Abbreviations: CON, lifestyle maintenance control group; INT, upper-body exercise 27 
intervention; MCS, mental component summary; PCS, physical component summary, QALY, 28 
quality-adjusted life years. 29 
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Table 1. Changes in outcome measures in response to 6 weeks of lifestyle maintenance (CON) or moderate-intensity upper-body exercise 
(INT).  
 CON (n = 8)  INT (n = 13) Cohens d     (90% 
CI) Inference 
Baseline Follow-up Δ (90% CI)  Baseline Follow-up Δ (90% CI) 
          
Body mass (kg) 76.8 ± 11.3 76.1 ± 10.6 -0.7 (-1.9, 0.6)  76.8 ± 13.3 75.7 ± 13.8 -1.1 (-1.9, -0.2) -0.03 (-0.15, 0.08) ‘Very likely trivial’ 
PAEE (kcal·d
-1
)
1
 342 ± 171 340 ± 179 -2 (-21, 17)  324 ± 161 433 ± 195# 109 (65, 153) 0.62 (0.36, 0.88)* ‘Very likely positive’  
MVPA (min·d
-1
)
1
 22 ± 30 19 ± 27 -3 (-7, 2)  13 ± 13 30 ± 19# 17 (11, 23) 0.90 (0.56, 1.24)* ‘Most likely positive’ 
   2 peak (ml·kg
-1
·min
-1
) 18.8 ± 6.2 18.3 ± 6.3 -0.5 (-1.0, 0.0)  18.3 ± 4.9 21.7 ± 5.1# 3.4 (2.6, 4.1) 0.68 (0.48, 0.75)* ‘Most likely positive’ 
Exercise self-efficacy 33 ± 5 29 ± 8 -4 (-9, 1)  31 ± 4 35 ± 4# 4 (1, 7) 1.37 (0.41, 2.32)* ‘Very likely positive’ 
PCS 66 ± 9 67 ± 11 1 (-4, 7)  55 ± 20 70 ± 20# 15 (8, 21) 0.75 (0.30, 1.20)* Very likely positive’ 
MCS 81 ± 12 80 ± 8 -1 (-6, 4)  68 ± 23 81 ± 19 13 (4, 22) 0.76 (0.21, 1.30) Very likely positive’ 
QALY 
0.741 ± 
0.097 
0.701 ± 
0.076 
-0.041 (-0.138, 
0.056) 
 
0.689 ± 
0.128 
0.747 ± 
0.128 
0.058 (0.016, 
0.101) 
0.82 (-0.04, 1.68) ‘Likely positive’ 
FSS 3.5 ± 1.1 3.9 ± 1.4 0.4 (-0.1, 0.8)  4.0 ± 1.1 3.2 ± 1.2# -0.8 (-1.2, -0.3) -0.99 (-1.75, -0.22)* ‘Very likely negative’ 
Global fatigue 7.3 ± 1.7 6.8 ± 1.9 -0.5 (-1.8, 0.9)  5.7 ± 2.7 7.4 ± 2.2 1.7 (0.4, 3.0) 0.92 (0.08, 1.76) ‘Likely positive’ 
WUSPI 19 ± 21 14 ± 15 -5 (-16, 6)  13 ± 11 13 ± 13 0 (-4, 4) 0.35 (-0.53, 1.24) ‘Unclear’ 
Table 1
 Values are means ± SD. Change scores (Δ) and standardised effect sizes are shown with 90% confidence intervals. None of the above variables 
differed significantly between groups at baseline (P ≥ 0.28). * denotes a day × group interaction (P ≤ 0.05) and # denotes values are different 
pre-post within INT group (P ≤ 0.05).  
1
 CON (n = 7) and INT (n = 12). Missing data are the result of monitor failure.  
Abbreviations: FSS, fatigue severity scale; MCS, mental component summary; MVPA, moderate-to-vigorous physical activity (≥ 3.0 METs); 
PAEE, physical activity energy expenditure; PCS, physical component summary; QALY, quality adjusted life years; WUSPI, wheelchair user 
shoulder pain index. 
Table 2. Pearson correlation coefficients between changes in (Δ) cardiorespiratory 
fitness, moderate-to-vigorous physical activity, exercise self-efficacy, SF-36 components, 
fatigue and shoulder pain from baseline to follow-up. Analyses are based on the 
treatment exposure analysis (n = 21). 
Outcome 
Δ    2 peak 
(ml·kg
-1
·min
-1
) 
Δ M PA 
(min·day
-1
) 
Δ Exercise 
self-efficacy
b
 
Δ PCS 0.52* 0.41 0.62† 
Δ MCSa 0.47* 0.40 0.71† 
Δ QALYb 0.44 0.50* -0.17 
Δ FSS -0.59† -0.55* -0.71† 
Δ Global fatigue  0.52* 0.22 0.57† 
Δ WUSPIb 0.31 0.21 -0.02 
Abbreviations: FSS, fatigue severity scale; MCS, mental component summary; MVPA, 
moderate-to-vigorous physical activity (≥ 3.0 METs); PCS, physical component summary; 
QALY, quality adjusted life years; WUSPI, wheelchair user shoulder pain index. 
a 
positively skewed so was log-transformed prior to parametric analysis.
 
b 
negatively skewed so was reflected prior to log-transformation 
* P < 0.05, † P < 0.01 
Table 2
Supplementary Table 1. Changes in outcome measures in response to 6 weeks of lifestyle maintenance (CON) or moderate-intensity 
upper-body exercise (INT), including participants (n = 2) excluded from the main analysis due to non-compliance.  
 CON (n = 8)  INT (n = 15) Cohens d     (90% 
CI) Inference 
Baseline Follow-up Δ (90% CI)  Baseline Follow-up Δ (90% CI) 
          
Body mass (kg) 76.8 ± 11.3 76.1 ± 10.6 -0.7 (-1.9, 0.6)  78.0 ± 13.0 77.2 ± 13.5 -0.8 (-1.6, -0.1) -0.02 (-0.13, 0.09) ‘Very likely trivial’ 
PAEE (kcal·d
-1
)
1
 342 ± 171 340 ± 179 -2 (-21, 17)  345 ± 171 439 ± 188# 94 (46, 142) 0.52 (0.25, 0.80)* ‘Very likely positive’  
MVPA (min·d
-1
)
1
 22 ± 30 19 ± 27 -3 (-7, 2)  16 ± 15 31 ± 19# 15 (9, 22) 0.80 (0.45, 1.14)* ‘Most likely positive’ 
   2 peak (ml·kg
-1
·min
-1
) 18.8 ± 6.2 18.3 ± 6.3 -0.5 (-1.0, 0.0)  17.8 ± 4.9 20.7 ± 5.5# 2.9 (2.1, 3.8) 0.60 (0.44, 0.76)* ‘Most likely positive’ 
Exercise self-efficacy 33 ± 5 29 ± 8 -4 (-9, 1)  32 ± 5 35 ± 4# 3 (1, 6) 1.25 (0.32, 2.19)* ‘Very likely positive’ 
PCS 66 ± 9 67 ± 11 1 (-4, 7)  60 ± 23  71 ± 19 11 (4, 18) 0.52 (0.05, 0.98) ‘Likely positive’ 
MCS 81 ± 12 80 ± 8 -1 (-6, 4)  70 ± 23 82 ± 18 12 (4, 20) 0.72 (0.21, 1.22) ‘Very likely positive’ 
QALY 
0.741 ± 
0.097 
0.701 ± 
0.076 
-0.041 (-0.138, 
0.056) 
 
0.716 ± 
0.130 
0.754 ± 
0.125 
0.038 (-0.004, 
0.08) 
0.65 (-0.21, 1.51) ‘Unclear’ 
FSS 3.5 ± 1.1 3.9 ± 1.4 0.4 (-0.1, 0.8)  3.9 ± 1.2 3.1 ± 1.1# -0.8 (-1.2, -0.3) -0.92 (-1.54, -0.29)* ‘Very likely negative’ 
Global fatigue 7.3 ± 1.7 6.8 ± 1.9 -0.5 (-1.8, 0.9)  6.0 ± 2.7 7.4 ± 2.3 1.4 (0.1, 2.6) 0.75 (-0.05, 1.55) ‘Likely positive’ 
WUSPI 19 ± 21 14 ± 15 -5 (-16, 6)  11 ± 10 12 ± 12 1 (-3, 5) 0.44 (-0.49, 1.38) ‘Unclear’ 
Supplementary Table 1
Values are means ± SD. Change scores (Δ) and standardised effect sizes are shown with 90% confidence intervals. * denotes a day × group 
interaction (P ≤ 0.05) and # denotes values are different pre-post within INT group (P ≤ 0.05).  
1
 CON (n = 7) and INT (n = 13). Missing data are the result of monitor failure and insufficient wear time criteria.  
Abbreviations: FSS, fatigue severity scale; MCS, mental component summary; MVPA, moderate-to-vigorous physical activity (≥ 3.0 METs); 
PAEE, physical activity energy expenditure; PCS, physical component summary; QALY, quality adjusted life years; WUSPI, wheelchair user 
shoulder pain index. 
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Section/Topic 
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No Checklist item 
Reported 
on page No 
Title and abstract 
 1a Identification as a randomised trial in the title 1 
1b Structured summary of trial design, methods, results, and conclusions (for specific guidance see CONSORT for abstracts) 2 
Introduction 
Background and 
objectives 
2a Scientific background and explanation of rationale 5-6 
2b Specific objectives or hypotheses 6 
Methods 
Trial design 3a Description of trial design (such as parallel, factorial) including allocation ratio 6-7 
3b Important changes to methods after trial commencement (such as eligibility criteria), with reasons NA 
Participants 4a Eligibility criteria for participants 8 
4b Settings and locations where the data were collected 8 
Interventions 5 The interventions for each group with sufficient details to allow replication, including how and when they were 
actually administered 
9-10 
Outcomes 6a Completely defined pre-specified primary and secondary outcome measures, including how and when they 
were assessed 
10 
6b Any changes to trial outcomes after the trial commenced, with reasons NA 
Sample size 7a How sample size was determined 7-8 
7b When applicable, explanation of any interim analyses and stopping guidelines NA 
Randomisation:    
 Sequence 
generation 
8a Method used to generate the random allocation sequence 7 
8b Type of randomisation; details of any restriction (such as blocking and block size) 7 
 Allocation 
concealment 
mechanism 
9 Mechanism used to implement the random allocation sequence (such as sequentially numbered containers), 
describing any steps taken to conceal the sequence until interventions were assigned 
7 
 Implementation 10 Who generated the random allocation sequence, who enrolled participants, and who assigned participants to 
interventions 
7 
Blinding 11a If done, who was blinded after assignment to interventions (for example, participants, care providers, those NA 
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assessing outcomes) and how 
11b If relevant, description of the similarity of interventions 7 
Statistical methods 12a Statistical methods used to compare groups for primary and secondary outcomes 11-12 
12b Methods for additional analyses, such as subgroup analyses and adjusted analyses 12 
Results 
Participant flow (a 
diagram is strongly 
recommended) 
13a For each group, the numbers of participants who were randomly assigned, received intended treatment, and 
were analysed for the primary outcome 
12 
13b For each group, losses and exclusions after randomisation, together with reasons 12 
Recruitment 14a Dates defining the periods of recruitment and follow-up 12 
14b Why the trial ended or was stopped 12 
Baseline data 15 A table showing baseline demographic and clinical characteristics for each group 12, Table 1 
Numbers analysed 16 For each group, number of participants (denominator) included in each analysis and whether the analysis was 
by original assigned groups 
12 
Outcomes and 
estimation 
17a For each primary and secondary outcome, results for each group, and the estimated effect size and its 
precision (such as 95% confidence interval) 
12-13,Table 1 
17b For binary outcomes, presentation of both absolute and relative effect sizes is recommended NA 
Ancillary analyses 18 Results of any other analyses performed, including subgroup analyses and adjusted analyses, distinguishing 
pre-specified from exploratory 
14, Table 2 
Harms 19 All important harms or unintended effects in each group (for specific guidance see CONSORT for harms) NA 
Discussion 
Limitations 20 Trial limitations, addressing sources of potential bias, imprecision, and, if relevant, multiplicity of analyses 19 
Generalisability 21 Generalisability (external validity, applicability) of the trial findings 20 
Interpretation 22 Interpretation consistent with results, balancing benefits and harms, and considering other relevant evidence 19 
Other information  
Registration 23 Registration number and name of trial registry Title Page 
Protocol 24 Where the full trial protocol can be accessed, if available Ref 15 
Funding 25 Sources of funding and other support (such as supply of drugs), role of funders Title Page 
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